Structure-based inhibition of protein-protein interactions

Andrew M. Watkins, Paramjit Arora

Research output: Contribution to journalArticle

Abstract

Protein-protein interactions (PPIs) are emerging as attractive targets for drug design because of their central role in directing normal and aberrant cellular functions. These interactions were once considered gundruggableg because their large and dynamic interfaces make small molecule inhibitor design challenging. However, landmark advances in computational analysis, fragment screening and molecular design have enabled development of a host of promising strategies to address the fundamental molecular recognition challenge. An attractive approach for targeting PPIs involves mimicry of protein domains that are critical for complex formation. This approach recognizes that protein subdomains or protein secondary structures are often present at interfaces and serve as organized scaffolds for the presentation of side chain groups that engage the partner protein(s). Design of protein domain mimetics is in principle rather straightforward but is enabled by a host of computational strategies that provide predictions of important residues that should be mimicked. Herein we describe a workflow proceeding from interaction network analysis, to modeling a complex structure, to identifying a high-affinity sub-structure, to developing interaction inhibitors. We apply the design procedure to peptidomimetic inhibitors of Ras-mediated signaling.

Original languageEnglish (US)
Pages (from-to)480-488
Number of pages9
JournalEuropean Journal of Medicinal Chemistry
Volume94
DOIs
StatePublished - Apr 13 2015

Fingerprint

Proteins
Peptidomimetics
Secondary Protein Structure
Workflow
Drug Design
Protein Transport
Molecular recognition
Electric network analysis
Scaffolds
Screening
Molecules
Protein Domains
Pharmaceutical Preparations

Keywords

  • Computational tools
  • Inhibitor design
  • Peptidomimetic
  • Protein structure
  • Protein-protein interaction

ASJC Scopus subject areas

  • Drug Discovery
  • Organic Chemistry
  • Pharmacology

Cite this

Structure-based inhibition of protein-protein interactions. / Watkins, Andrew M.; Arora, Paramjit.

In: European Journal of Medicinal Chemistry, Vol. 94, 13.04.2015, p. 480-488.

Research output: Contribution to journalArticle

@article{4acf1b7d95754b0685440690ef650c09,
title = "Structure-based inhibition of protein-protein interactions",
abstract = "Protein-protein interactions (PPIs) are emerging as attractive targets for drug design because of their central role in directing normal and aberrant cellular functions. These interactions were once considered gundruggableg because their large and dynamic interfaces make small molecule inhibitor design challenging. However, landmark advances in computational analysis, fragment screening and molecular design have enabled development of a host of promising strategies to address the fundamental molecular recognition challenge. An attractive approach for targeting PPIs involves mimicry of protein domains that are critical for complex formation. This approach recognizes that protein subdomains or protein secondary structures are often present at interfaces and serve as organized scaffolds for the presentation of side chain groups that engage the partner protein(s). Design of protein domain mimetics is in principle rather straightforward but is enabled by a host of computational strategies that provide predictions of important residues that should be mimicked. Herein we describe a workflow proceeding from interaction network analysis, to modeling a complex structure, to identifying a high-affinity sub-structure, to developing interaction inhibitors. We apply the design procedure to peptidomimetic inhibitors of Ras-mediated signaling.",
keywords = "Computational tools, Inhibitor design, Peptidomimetic, Protein structure, Protein-protein interaction",
author = "Watkins, {Andrew M.} and Paramjit Arora",
year = "2015",
month = "4",
day = "13",
doi = "10.1021/sb400168u",
language = "English (US)",
volume = "94",
pages = "480--488",
journal = "European Journal of Medicinal Chemistry",
issn = "0223-5234",
publisher = "Elsevier Masson SAS",

}

TY - JOUR

T1 - Structure-based inhibition of protein-protein interactions

AU - Watkins, Andrew M.

AU - Arora, Paramjit

PY - 2015/4/13

Y1 - 2015/4/13

N2 - Protein-protein interactions (PPIs) are emerging as attractive targets for drug design because of their central role in directing normal and aberrant cellular functions. These interactions were once considered gundruggableg because their large and dynamic interfaces make small molecule inhibitor design challenging. However, landmark advances in computational analysis, fragment screening and molecular design have enabled development of a host of promising strategies to address the fundamental molecular recognition challenge. An attractive approach for targeting PPIs involves mimicry of protein domains that are critical for complex formation. This approach recognizes that protein subdomains or protein secondary structures are often present at interfaces and serve as organized scaffolds for the presentation of side chain groups that engage the partner protein(s). Design of protein domain mimetics is in principle rather straightforward but is enabled by a host of computational strategies that provide predictions of important residues that should be mimicked. Herein we describe a workflow proceeding from interaction network analysis, to modeling a complex structure, to identifying a high-affinity sub-structure, to developing interaction inhibitors. We apply the design procedure to peptidomimetic inhibitors of Ras-mediated signaling.

AB - Protein-protein interactions (PPIs) are emerging as attractive targets for drug design because of their central role in directing normal and aberrant cellular functions. These interactions were once considered gundruggableg because their large and dynamic interfaces make small molecule inhibitor design challenging. However, landmark advances in computational analysis, fragment screening and molecular design have enabled development of a host of promising strategies to address the fundamental molecular recognition challenge. An attractive approach for targeting PPIs involves mimicry of protein domains that are critical for complex formation. This approach recognizes that protein subdomains or protein secondary structures are often present at interfaces and serve as organized scaffolds for the presentation of side chain groups that engage the partner protein(s). Design of protein domain mimetics is in principle rather straightforward but is enabled by a host of computational strategies that provide predictions of important residues that should be mimicked. Herein we describe a workflow proceeding from interaction network analysis, to modeling a complex structure, to identifying a high-affinity sub-structure, to developing interaction inhibitors. We apply the design procedure to peptidomimetic inhibitors of Ras-mediated signaling.

KW - Computational tools

KW - Inhibitor design

KW - Peptidomimetic

KW - Protein structure

KW - Protein-protein interaction

UR - http://www.scopus.com/inward/record.url?scp=84939970800&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939970800&partnerID=8YFLogxK

U2 - 10.1021/sb400168u

DO - 10.1021/sb400168u

M3 - Article

C2 - 25253637

AN - SCOPUS:84939970800

VL - 94

SP - 480

EP - 488

JO - European Journal of Medicinal Chemistry

JF - European Journal of Medicinal Chemistry

SN - 0223-5234

ER -